Biomaterials companies are organizations that specialize in the development, manufacturing, and commercialization of materials designed for use in medical and healthcare applications. These materials are often used to interact with biological systems, such as the human body, and can serve various purposes, including medical devices, tissue engineering, drug delivery, and diagnostic tools.
Covation Biomaterials: Emerged as an independent business after the Huafon Group acquired DuPont Biomaterials, expanding its portfolio of bio-based solutions.
Novo Nordisk: Collaborated with Aspect Biosystems to develop bioprinted tissue therapeutics for chronic diseases like obesity and diabetes, leveraging 3D printing technology for personalized medicine.
Mitsubishi Chemical: Acquired AdvanSource Biomaterials' thermoplastic polyurethane elastomer business, strengthening its global footprint in the biomaterials market.
Stryker's Qb2 InvisiFilm™: A resorbable biomaterial film for minimally invasive surgery, designed to provide temporary support and reinforcement while disappearing gradually without the need for removal.
Exparel® with Hydromorph (OXN/HCL): A new extended-release pain relief injection developed by Pacira Pharmaceuticals, offering long-lasting pain relief for orthopedic surgeries.
Biotronik's Magnis Resorbable Stent: The first fully resorbable stent approved by the FDA, designed to dissolve within two years after implantation, potentially reducing long-term complications.
Biomaterial Market Highlights:
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)